Syndax Pharmaceuticals

Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company advancing innovative cancer therapies. Highlights of the Company’s pipeline include a menin inhibitor for R/R acute leukemia and a monoclonal antibody that blocks the CSF-1 receptor for chronic graft-versus-host disease. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. Review our social media community guidelines below: https://syndax.com/social-media-community-guidelines/

Celldex

Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders.

Thomas Scientific

Thomas Scientifics’ guiding principle is “We Believe You Are Important” and this belief guides our every action and investment. We have been delivering quality laboratory supplies and scientific equipment to the worldwide scientific market since 1900. We are a full-line stocking distributor and have developed a broad portfolio of products to support your operational needs, including: Supplies and Consumables, Equipment, Instruments and Furniture, Chemicals and Reagents, as well as Laboratory and Facility Safety and Apparel. Thomas Scientific operates as a classic distributor with a robust sales team to fully support your needs, as well as an online procurement operation in North America and Internationally for Laboratory Supplies and Consumables, Equipment, Instruments and Furniture, Chemicals, and Laboratory Safety and Apparel. Our website, ThomasSci.com, operates as a wholesale and retail Website. Thomas Scientific serves Science through ThomasSci.com and focuses on selection, price, and convenience.

geneid lab, advanced molecular diagnostics

Disease Prevention...that is what GeneID, Advanced Molecular Diagnostics has been focused on since 2012! GeneID is a CLIA and CAP Accredited, Molecular Testing Laboratory specializing in Next Generation Gene DNA Sequencing. Our testing searches for DNA mutations known to contribute to the development of certain Solid Tumor Cancers which make up approximately 800,000 new cases per year.(Breast, Ovarian, Colon, Prostate, Pancreas, Stomach, Uterine, and Skin Cancers) so that a Preventative plan can be put in place to reduce cancer risk. Additionally, GeneID specializes in Carrier Testing, which can help prospective parents reduce the risk of having a child born with a devastating hereditary disease associated with a shortened life span and poor quality of life such as Cystic Fibrosis, Sickle Cell Anemia, Spinal Muscular Atrophy, and about 60 other childhood diseases. GeneID's Scientific team is led by an OB/GYN, Geneticist who spent 7 years working on the Human Genome Project,. specifically on the BRCA 1 and 2 genes. GeneID has been recognized by the College of American Pathology as "Model for other Molecular Laboratories"​ due to the unique testing and quality measures incorporated into our testing process, resulting in the highest level of test accuracy.

Anima Biotech

Anima is a Tech.Bio company at the intersection of mRNA biology and AI. We are advancing the mRNA Lightning platform for the discovery of small molecule mRNA drugs and novel mRNA biology targets. Built from the ground up with over a decade of expertise in mRNA biology, the platform integrates mRNA biology with AI imaging technologies to visualize the entire life cycle of mRNA in cells and decode the mRNA biology underlying a disease. Utilizing millions of images from both healthy and diseased cells, we train disease-specific mRNA image analysis neural networks to recognize a disease signature, an mRNA biology pathway that underlies disease phenotype. Our tera-scale mRNA biology lab then conducts high content screening from our optimized library of mRNA modulators, sending the images to our mRNA image neural network to identify active compounds, the molecules that visually alter the mRNA biology signature. Our MOAi technology, the mRNA biology large language model and the Lightning co-pilot work along the process to elucidate the mechanisms of action and molecular targets. Anima’s mRNA Lightning platform is validated by our strategic collaborations with Lilly, Takeda, and AbbVie across therapeutic areas and a pipeline of 20 drug discovery programs.